GP1BA: Platelet glycoprotein Ib alpha chain
GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium.
- Drugs that act on it: 1
- Approved: 0
- In phases 1 to 3: 1
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on GP1BA, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Protein or peptide 1
| Drug | Furthest stage | Sponsor | Modality | Action | Open trials |
|---|---|---|---|---|---|
| Anfibatide | Phase 2 | Lee's Pharm | Protein or peptide | AntagonistPlatelet glycoprotein Ib alpha chain antagonist | 1 |
| Trial | Drug | Phase | Status | Lead sponsor | First posted |
|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy Volunteers | Anfibatide | Phase 1 | Not yet recruiting | Lee's Pharmaceutical Limited | Oct 21, 2026 |
- Bernard-Soulier syndrome0.83
- Platelet-type von Willebrand disease0.78
- Hereditary optic neuropathy0.62
- Macrothrombocytopenia0.48
- Thrombocytopenia0.47
- Autosomal dominant macrothrombocytopenia0.39
- Brooke-Spiegler syndrome0.37
- Abnormal bleeding0.34
- Impaired ristocetin-induced platelet aggregation0.27
- Hereditary disease0.19
- Mathematical ability0.19
- Autoimmune thrombocytopenic purpura0.10
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4630891, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt P07359, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets